MEETING THE CHALLENGE OF ATOPIC DERMATITIS FROM INFANCY TO ADULTHOOD
Introduction
Meeting the Challenge of Atopic Dermatitis from Infancy to Adulthood, Introduction
Dermatologists and primary care clinicians have been able to adequately manage most patients with atopic dermatitis (AD), using long-standing and familiar nonpharmacologic and pharmacologic interventions.
Practical Strategies for the Diagnosis and Assessment of Atopic Dermatitis
Atopic dermatitis (AD) has a significant, lifelong clinical impact on affected individuals and has profound effects on quality of life both for patients and their families.
If you would like to complete the CME portion of this Supplement, please click here.
Atopic Dermatitis Progression: Evaluating Intervention Strategies
Several risk factors have been identified that appear to be consistently and strongly associated with the development of atopic dermatitis (AD): a family history of atopy, an inherited genetic predisposition, and active and passive exposure to tobacco smoke.
If you would like to complete the CME portion of this Supplement, please click here.
Nonpharmacologic Strategies and Topical Agents for Treating Atopic Dermatitis: An Update
The signs and symptoms of atopic dermatitis can be safely and effectively controlled in most patients; in many cases, the disease can be improved to the point that signs and symptoms are absent or minimal. In addition, flares can be effectively controlled and, in some cases, prevented.
If you would like to complete the CME portion of this Supplement, please click here.
Addressing the Immunopathogenesis of Atopic Dermatitis: Advances in Topical and Systemic Treatment
Several immunologic mediators—phosphodiesterase (PDE), interleukin (IL), small molecules, and Janus kinase—have been implicated in the pathogenesis of atopic dermatitis, and evidence has shown that blocking these mediators can help modify the disease process.
Eichenfield LF, Stein Gold LF. Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment. Sem Cutan Med Surg. 2017;36(Suppl 2):S45-S48. https://doi.org/10.12788/j.sder.2017.012.
If you would like to complete the CME portion of this Supplement, please click here.